Search research articles
Contact Us
Filters
Showing results (181-190 of 314) with videos related to
Page
of 32
Sort By:
The Lancet. Oncology
|
December 3, 2005
Health-related quality of life in patients with glioblastoma: a randomised controlled trial
Martin J B Taphoorn, Roger Stupp, Corneel Coens, et al.
Neuro-Oncology
|
October 24, 2012
EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma
Enrico Franceschi, Roger Stupp, Martin J van den Bent, et al.
Journal of Neuro-Oncology
|
June 12, 2024
Long-term outcomes of central neurocytoma - an institutional experience
Yufan Yang, Nitin Wadhwani, Aoi Shimomura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 31, 2024
Paclitaxel and Carboplatin in Combination with Low-intensity Pulsed Ultrasound for Glioblastoma
Karl J Habashy, Crismita Dmello, Li Chen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 3, 2012
New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: a pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials
Thierry Gorlia, Roger Stupp, Alba A Brandes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2010
Long-term follow-up of patients with follicular lymphoma receiving single-agent rituximab at two different schedules in trial SAKK 35/98
Giovanni Martinelli, Shu-Fang Hsu Schmitz, Urs Utiger, et al.
BMC Cancer
|
January 17, 2013
A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors
Joseph P Connor, Mihaela C Cristea, Nancy L Lewis, et al.
Journal of Clinical Apheresis
|
March 23, 2016
Efficacious and save use of biosimilar filgrastim for hematopoietic progenitor cell chemo-mobilization with vinorelbine in multiple myeloma patients
Julia-Tatjana Maul, Frank Stenner-Liewen, Burkhardt Seifert, et al.
Oncotarget
|
September 15, 2016
PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status
Kenney R Roodakker, Tamador Elsir, Per-Henrik D Edqvist, et al.
Advances in Oncology
|
October 20, 2023
Advances in Blood-Brain Barrier Disruption to Facilitate Drug Delivery for Infiltrative Gliomas
Andrew Gould, Victor Andrés Arrieta Gonzales, Crismita Clement Dmello, et al.
Page
of 32
Search research articles
Search
Showing results (181-190 of 314) with videos related to
Sort By:
Page
of 32
The Lancet. Oncology
|
December 3, 2005
Health-related quality of life in patients with glioblastoma: a randomised controlled trial
Martin J B Taphoorn, Roger Stupp, Corneel Coens, et al.
Neuro-Oncology
|
October 24, 2012
EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma
Enrico Franceschi, Roger Stupp, Martin J van den Bent, et al.
Journal of Neuro-Oncology
|
June 12, 2024
Long-term outcomes of central neurocytoma - an institutional experience
Yufan Yang, Nitin Wadhwani, Aoi Shimomura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 31, 2024
Paclitaxel and Carboplatin in Combination with Low-intensity Pulsed Ultrasound for Glioblastoma
Karl J Habashy, Crismita Dmello, Li Chen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 3, 2012
New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: a pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials
Thierry Gorlia, Roger Stupp, Alba A Brandes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2010
Long-term follow-up of patients with follicular lymphoma receiving single-agent rituximab at two different schedules in trial SAKK 35/98
Giovanni Martinelli, Shu-Fang Hsu Schmitz, Urs Utiger, et al.
BMC Cancer
|
January 17, 2013
A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors
Joseph P Connor, Mihaela C Cristea, Nancy L Lewis, et al.
Journal of Clinical Apheresis
|
March 23, 2016
Efficacious and save use of biosimilar filgrastim for hematopoietic progenitor cell chemo-mobilization with vinorelbine in multiple myeloma patients
Julia-Tatjana Maul, Frank Stenner-Liewen, Burkhardt Seifert, et al.
Oncotarget
|
September 15, 2016
PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status
Kenney R Roodakker, Tamador Elsir, Per-Henrik D Edqvist, et al.
Advances in Oncology
|
October 20, 2023
Advances in Blood-Brain Barrier Disruption to Facilitate Drug Delivery for Infiltrative Gliomas
Andrew Gould, Victor Andrés Arrieta Gonzales, Crismita Clement Dmello, et al.
Page
of 32